Bicameral Pact Uses Market Forces To Push Compounders Toward Voluntary Federal Oversight Lawmakers late Wednesday (Sept. 26) struck a bicameral, bipartisan drug compounding agreement that departs from previous proposals by ditching volume limits and a three-part test in favor of a voluntary regulatory scheme for sterile compounders.
No comments:
Post a Comment